Drug Shortage Report for CEFTRIAXONE INJECTION, USP

Last updated on 2022-08-17 History
Report ID 162666
Drug Identification Number 02499711
Brand name CEFTRIAXONE INJECTION, USP
Common or Proper name CEFTRIAXONE INJECTION, USP
Company Name BAXTER CORPORATION
Market Status MARKETED
Active Ingredient(s) CEFTRIAXONE
Strength(s) 1000MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 50mL
ATC code J01DD
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2022-06-17
Actual start date 2022-06-17
Estimated end date 2022-08-16
Actual end date 2022-08-16
Shortage status Resolved
Updated date 2022-08-17
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 7125 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 0C2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2022-08-17 English Compare
v12 2022-08-16 French Compare
v11 2022-08-16 English Compare
v10 2022-08-02 French Compare
v9 2022-08-02 English Compare
v8 2022-07-04 French Compare
v7 2022-07-04 English Compare
v6 2022-06-29 French Compare
v5 2022-06-29 English Compare
v4 2022-06-18 English Compare
v3 2022-06-15 French Compare
v2 2022-06-15 English Compare
v1 2022-06-15 English Compare

Showing 1 to 13 of 13